Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 65 peer-reviewed journal articles Updated
Ophthalmology

Choroideremia (CHM) Resource Guide

At a Glance

Choroideremia (CHM) is a slow-moving genetic eye disease that causes progressive vision loss. Because most patients retain functional central vision for decades, there is ample time to understand your specific genetic mutation, build a care team, and explore emerging treatments like gene therapy.

Receiving a diagnosis of Choroideremia (CHM) can feel overwhelming. Hearing the words “progressive vision loss” often triggers a panic spiral. This guide is designed to stop that spiral, validate your experience, and provide you with a strategic, evidence-based roadmap for living with this condition.

While CHM is a serious genetic disease, it is also a slow-moving one. Most patients retain functional, central vision for decades, which means you have the most valuable resource of all: time. Time to plan, time to adapt, and time to build a robust care team.

This guide will help you understand your diagnosis, interpret your lab reports, and navigate the evolving world of clinical trials.

Navigating This Guide

We have broken down the information into specific, focused pages so you can learn at your own pace:

01

Validation & Orientation: Understanding Choroideremia

Learn what a Choroideremia (CHM) diagnosis means for your vision. Understand the slow progression, symptoms like night blindness, and the impact on carriers.

02

The Progression of Vision Loss in Choroideremia

Learn about the progression of vision loss in Choroideremia (CHM). Understand the stages, from early night blindness to peripheral and central vision changes.

03

The Biology and Genetics of Choroideremia

Learn how the CHM gene mutation causes Choroideremia. Understand the role of the REP-1 protein, X-linked inheritance rules, and how CHM differs from RP.

04

Clinical Tests, Imaging & Lab Reports

Learn how to read your Choroideremia (CHM) test results. Understand why FAF and OCT imaging matter more than eye charts, and decode your genetic lab report.

05

Standard of Care & Ongoing Monitoring

Learn about the standard of care and longitudinal monitoring for Choroideremia (CHM). Understand key tests like FAF and OCT, and how care changes with age.

06

Emerging Treatments & Clinical Trials

Explore emerging treatments and clinical trials for Choroideremia (CHM). Learn about gene therapy, ASOs, surgical risks, and how to enroll in research.

07

Survivorship, Quality of Life & Building Your Care Team

Learn how to build a multidisciplinary care team for Choroideremia (CHM). Discover strategies to manage scan anxiety and use low vision tools to adapt.

You do not need to read everything today. Bookmark this page, take a deep breath, and explore the topics as you are ready.

Common questions in this guide

What is my exact genetic mutation for Choroideremia?
Your specific genetic mutation, which typically involves the REP-1 protein, determines your exact diagnosis. You can request a copy of your genetic lab report from your doctor or genetic counselor to keep for your personal medical records.
How do I know what stage of Choroideremia I am in?
Choroideremia is a progressive disease that moves slowly over decades. Your ophthalmologist can perform imaging tests like OCT and FAF to determine your current stage and provide a realistic timeline for future vision changes.
Should I see a genetic counselor after a CHM diagnosis?
Yes, speaking with a genetic counselor is highly recommended. They can help you understand the complex inheritance pattern of the disease, discuss family planning options, and connect you with clinical trial registries.
Will I lose all my vision from Choroideremia rapidly?
While Choroideremia causes progressive vision loss, including night blindness and peripheral vision loss, it is a very slow-moving condition. Most patients retain functional, central vision for decades, allowing time to adapt and plan.

Get notified when new evidence is published on Choroideremia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

This Choroideremia guide is for informational purposes only and does not replace professional medical advice. Always consult your ophthalmologist or genetic counselor about your specific vision changes and care plan.